Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer

Rola Husni; Ray Hachem; Hend Hanna; Issam Raad

doi:10.1086/502016

Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer

Rola Husni, Ray Hachem, Hend Hanna, Issam Raad

Infectious Diseases, Infection Control, and Employee Health

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Abstract

To determine the risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer, we conducted a case-control study. According to multivariate analysis, the only significant factors were neutropenia (< 500 cells/mm³) for more than 1 week and the use of oral vancomycin. Therefore, colonized neutropenic patients with cancer who have previously used oral vancomycin are most prone to VRE infection.

Original language	English (US)
Pages (from-to)	102-103
Number of pages	2
Journal	Infection Control and Hospital Epidemiology
Volume	23
Issue number	2
DOIs	https://doi.org/10.1086/502016
State	Published - 2002

ASJC Scopus subject areas

Epidemiology
Microbiology (medical)
Infectious Diseases

Access to Document

10.1086/502016

Cite this

@article{612b5c2d0ba240db91cdc98b9f24eeef,

title = "Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer",

abstract = "To determine the risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer, we conducted a case-control study. According to multivariate analysis, the only significant factors were neutropenia (< 500 cells/mm3) for more than 1 week and the use of oral vancomycin. Therefore, colonized neutropenic patients with cancer who have previously used oral vancomycin are most prone to VRE infection.",

author = "Rola Husni and Ray Hachem and Hend Hanna and Issam Raad",

year = "2002",

doi = "10.1086/502016",

language = "English (US)",

volume = "23",

pages = "102--103",

journal = "Infection Control and Hospital Epidemiology",

issn = "0899-823X",

publisher = "University of Chicago Press",

number = "2",

}

TY - JOUR

T1 - Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer

AU - Husni, Rola

AU - Hachem, Ray

AU - Hanna, Hend

AU - Raad, Issam

PY - 2002

Y1 - 2002

N2 - To determine the risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer, we conducted a case-control study. According to multivariate analysis, the only significant factors were neutropenia (< 500 cells/mm3) for more than 1 week and the use of oral vancomycin. Therefore, colonized neutropenic patients with cancer who have previously used oral vancomycin are most prone to VRE infection.

AB - To determine the risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer, we conducted a case-control study. According to multivariate analysis, the only significant factors were neutropenia (< 500 cells/mm3) for more than 1 week and the use of oral vancomycin. Therefore, colonized neutropenic patients with cancer who have previously used oral vancomycin are most prone to VRE infection.

UR - http://www.scopus.com/inward/record.url?scp=0036189636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036189636&partnerID=8YFLogxK

U2 - 10.1086/502016

DO - 10.1086/502016

M3 - Article

C2 - 11893144

AN - SCOPUS:0036189636

SN - 0899-823X

VL - 23

SP - 102

EP - 103

JO - Infection Control and Hospital Epidemiology

JF - Infection Control and Hospital Epidemiology

IS - 2

ER -

Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this